Galera Therapeutics, Inc. (GRTX) has 31 open-market insider trades by 15 insiders since 2014. The most active filer is Linda West, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Novo Holdings A/S | 10% Owner | — | 3 | $16.2M | 2021-02-18 |
| James Healy | Dir10% Owner | — | 1 | $9.0M | 2019-11-12 |
| Novartis Bioventures Ltd | — | — | 3 | $8.9M | 2020-06-19 |
| David M. Mott | 10% Owner | — | 1 | $5.0M | 2019-11-12 |
| Ag Novartis | 10% Owner | — | 3 | $3.5M | 2020-06-17 |
| Blackstone Holdings II L.P. | 10% Owner | — | 1 | $3.0M | 2019-11-12 |
| Nancy T. Chang | Dir10% Owner | — | 1 | $1.1M | 2024-12-30 |
| Yair Schneid | 10% Owner | — | 2 | $1.0M | 2024-04-19 |
| Jon T. Holmlund | — | — | 3 | $592K | 2021-09-01 |
| Linda West | Dir | — | 4 | $552K | 2021-12-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mel Sorensen | President | Sell | $1K | 2025-11-20 |
| Nancy T. Chang | Director & 10% Owner | Buy | $1.1M | 2024-12-30 |
| Mel Sorensen | President | Sell | $5K | 2024-08-16 |
| Yair Schneid | 10% Owner | Buy | $165K | 2024-01-29 |
| Altamont Pharmaceutical Holdings, LLC | 10% Owner | Sell | $820K | 2024-01-11 |
| Mark Bachleda | Chief Commercial Officer | Buy | $25K |
Companies that share insiders with GRTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-03-16 |
| Chris Degnan | CFO | Buy | $20K | 2023-03-13 |
| Mel Sorensen | CEO & President | Buy | $168K | 2023-03-10 |
| Linda West | Director | Buy | $110K | 2021-12-17 |
| Jon T. Holmlund | — | Sell | $809K | 2021-09-01 |
| Linda West | Director | Buy | $183K | 2021-06-15 |
| Linda West | Director | Buy | $87K | 2021-06-02 |
| Lawrence M. Alleva | Director | Buy | $35K | 2021-06-01 |
| Linda West | Director | Buy | $173K | 2021-05-28 |
| Novo Holdings A/S | 10% Owner | Sell | $5.3M | 2021-02-18 |